Junli He bought $380K of Harvard Apparatus Regenerative Technology (HRGN)

Executed Sep 11, disclosed Sep 25, 14 days later, against a two-business-day limit.

Value, as filed

$380K

361,905 sh × $1.05

Executed

Sep 11

the trade date, as filed

Disclosed

Sep 25

14 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

Junli He CEO profile →

Junli He (CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales, 1 filed past the two-business-day deadline), most often in Harvard Apparatus Regenerative Technology Inc. (HRGN). The largest single filing was $380K of HRGN (361,905 sh × $1.05, as filed), executed Sep 11. The median gap between execution and disclosure was 14 days.

The name

HRGN

Harvard Apparatus Regenerative Technology Inc. HRGN · Consumer Defensive · 1 filing in 24 months ticker →

Consumer Defensive · Harvard Apparatus Regenerative Technology Inc., a clinical-stage biotechnology company, focuses on developing regenerative-medicine treatme…

More Consumer Defensive filings→ Insider filings, newest first→ View the original filing at www.sec.gov→